HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Impact of Hypertension on the Clinicopathological Outcome and Progression of Renal Cell Carcinoma.

AbstractBACKGROUND/AIM:
Hypertension is a risk factor for occurrence of renal cell carcinoma; however, it remains unclear whether hypertension affects development and prognosis of renal cell carcinoma. This study evaluated the impact of hypertension on the progression of renal cell carcinoma.
PATIENTS AND METHODS:
Renal cell carcinoma patients who were treated from October 2007 to December 2018 at our Institution were retrospectively analyzed.
RESULTS:
Of 462 patients, the number of patients with and without hypertension was 234 (including 227 treated with anti-hypertensive agents) and 228, respectively. The tumor size was significantly smaller in the hypertension group than in the non-hypertension group (median 32 and 45 mm, respectively, p=0.010). The 5-year cancer-specific and metastasis-free survival in the hypertension group were significantly better than those in the non-hypertension group (93.6% and 80.4%, and 84.6% and 73.0%, respectively, p=0.021 and p=0.017). Propensity score matching revealed significantly better metastatic-free survival in the hypertension group than the non-hypertension group (p=0.022).
CONCLUSION:
Renal cell carcinoma patients with hypertension show better prognosis with low metastasis possibility.
AuthorsTomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Renato Naito, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
JournalAnticancer research (Anticancer Res) Vol. 40 Issue 7 Pg. 4087-4093 (Jul 2020) ISSN: 1791-7530 [Electronic] Greece
PMID32620657 (Publication Type: Journal Article)
CopyrightCopyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Chemical References
  • Antihypertensive Agents
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents (therapeutic use)
  • Carcinoma, Renal Cell (epidemiology, pathology)
  • Disease Progression
  • Female
  • Humans
  • Hypertension (drug therapy, epidemiology)
  • Kidney Neoplasms (epidemiology, pathology)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Tumor Burden
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: